Physician

Vikas Bhushan, M.D.

According to 2025 Medicare claims, Vikas Bhushan, M.D. (NPI: 1285677138) practices hematology/oncology in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Dallas, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1003083445; TIN: 752131429) and primary practice location at 75230-2571.

Bhushan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 676 traditional Medicare patients, billed 182,765 HCPCS/CPT codes, and received $2,695,290 in Medicare payments. The top billing code was 99232 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes). Part D data shows 1,317 prescription claims across 257 beneficiaries totaling $4,462,416 in drug costs, led by Ayvakit (Avapritinib). 2023 DME data shows 30 claims. Open Payments data shows 5 records totaling $10,774. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,571,569 to $2,695,290. Similarly, Part D prescription costs have risen steadily, from $2,179,539 to $4,462,416. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $3,427 and ending at $5,293.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	283	171,405	$1,571,569
2016	430	152,267	$1,525,101
2017	553	160,851	$2,021,464
2018	598	202,311	$2,977,570
2019	642	120,380	$2,299,243
2020	659	205,974	$3,243,603
2021	694	192,432	$3,072,158
2022	671	207,898	$2,690,772
2023	669	162,278	$2,471,185
2024	676	182,765	$2,695,290

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	181	2,056	$2,179,539
2016	223	2,499	$2,995,200
2017	248	2,303	$3,311,613
2018	284	2,869	$3,713,023
2019	294	2,238	$4,155,469
2020	292	1,833	$5,414,687
2021	265	1,820	$4,501,141
2022	274	1,829	$4,468,084
2023	252	1,587	$4,060,726
2024	257	1,317	$4,462,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	57	$2,592
2016	N/R	52	$5,773
2017	N/R	38	$1,290
2018	23	180	$7,206
2019	12	151	$4,247
2020	N/R	72	$2,527
2021	N/R	37	$732
2022	11	109	$2,268
2023	N/R	30	$540
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	210	1,958	$60
80053	Blood test, comprehensive group of blood chemicals	270	652	$10
36415	Insertion of needle into vein for collection of blood sample	212	432	$9
83735	Magnesium level	270	646	$7
83615	Lactate dehydrogenase (enzyme) level	269	645	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ayvakit	Avapritinib	28	840	$1,096,393
Pomalyst	Pomalidomide	35	868	$618,543
Rezurock	Belumosudil Mesylate	17	510	$510,505
Jakafi	Ruxolitinib Phosphate	29	870	$468,897
Ojjaara	Momelotinib Dihydrochloride	12	360	$336,580

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$1,799	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$8,975	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vikas Bhushan, M.D.?

Tedicare shows public-source Medicare data for Vikas Bhushan, M.D. (NPI 1285677138), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vikas Bhushan, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Vikas Bhushan, M.D.?

Vikas Bhushan, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1003083445) in the available physician profile data.

Does Vikas Bhushan, M.D. have Open Payments data?

Vikas Bhushan, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.